The Claim
Rosuvastatin 10 mg daily for 24 weeks reduces low-density lipoprotein (LDL) cholesterol by approximately 28% in HIV-infected adults with baseline LDL ≤130 mg/dL, despite the absence of traditional hyperlipidemia.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In HIV-infected adults with normal cholesterol levels, taking 10 mg of rosuvastatin daily for 24 weeks lowers LDL cholesterol by about 28%.
See the scientific wording
Rosuvastatin 10 mg daily for 24 weeks reduces low-density lipoprotein (LDL) cholesterol by approximately 28% in HIV-infected adults with baseline LDL ≤130 mg/dL, despite the absence of traditional hyperlipidemia, indicating a lipid-lowering effect even in normolipidemic populations.
Rosuvastatin blocks a key enzyme in the liver that makes cholesterol. This causes the liver to make more receptors that grab LDL cholesterol from the blood and pull it into the liver to be broken down. As a result, less LDL stays in the bloodstream, lowering its levels even when they start out normal.
What the research says
1 studyIn people with HIV who had normal cholesterol, taking a common statin pill (rosuvastatin) for 6 months lowered their bad cholesterol by about 28%, even though it wasn't high to begin with. This proves the drug works to reduce cholesterol even in people without high levels.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.